Concepts (76)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatitis C | 3 | 2020 | 139 | 0.810 |
Why?
|
| Hepacivirus | 1 | 2020 | 74 | 0.640 |
Why?
|
| Pharmacy | 1 | 2021 | 34 | 0.320 |
Why?
|
| Education, Pharmacy | 1 | 2021 | 57 | 0.320 |
Why?
|
| Opioid-Related Disorders | 2 | 2024 | 195 | 0.290 |
Why?
|
| Ambulatory Care | 2 | 2006 | 81 | 0.290 |
Why?
|
| Drug Prescriptions | 2 | 2006 | 60 | 0.250 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2006 | 44 | 0.240 |
Why?
|
| District of Columbia | 3 | 2020 | 80 | 0.220 |
Why?
|
| Dementia | 1 | 2006 | 160 | 0.210 |
Why?
|
| Retrospective Studies | 4 | 2021 | 2544 | 0.190 |
Why?
|
| United States | 6 | 2024 | 5205 | 0.170 |
Why?
|
| Hospitals, Urban | 1 | 2020 | 42 | 0.170 |
Why?
|
| Hospitals, Teaching | 1 | 2020 | 33 | 0.160 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2019 | 20 | 0.160 |
Why?
|
| Narcotic Antagonists | 1 | 2019 | 78 | 0.150 |
Why?
|
| Pharmacogenetics | 1 | 2019 | 67 | 0.150 |
Why?
|
| Herpes Zoster Vaccine | 1 | 2018 | 2 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 989 | 0.150 |
Why?
|
| Vitamins | 1 | 2019 | 81 | 0.140 |
Why?
|
| Antiviral Agents | 1 | 2020 | 195 | 0.140 |
Why?
|
| Vitamin D Deficiency | 1 | 2019 | 107 | 0.130 |
Why?
|
| Medication Adherence | 1 | 2019 | 182 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 179 | 0.130 |
Why?
|
| Population Growth | 1 | 2017 | 8 | 0.130 |
Why?
|
| Health Literacy | 1 | 2019 | 130 | 0.130 |
Why?
|
| Vitamin D | 1 | 2019 | 196 | 0.130 |
Why?
|
| Intention | 1 | 2017 | 108 | 0.120 |
Why?
|
| Vaccination | 1 | 2018 | 355 | 0.120 |
Why?
|
| Male | 8 | 2021 | 23409 | 0.120 |
Why?
|
| Humans | 13 | 2024 | 43102 | 0.110 |
Why?
|
| Public Health | 1 | 2018 | 424 | 0.100 |
Why?
|
| Female | 11 | 2024 | 24698 | 0.100 |
Why?
|
| Middle Aged | 7 | 2024 | 12222 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2018 | 719 | 0.090 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 3156 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2021 | 102 | 0.080 |
Why?
|
| Bone Density Conservation Agents | 1 | 2010 | 28 | 0.080 |
Why?
|
| Health Surveys | 2 | 2024 | 405 | 0.080 |
Why?
|
| Aged | 5 | 2019 | 8214 | 0.080 |
Why?
|
| Osteoporosis | 1 | 2010 | 45 | 0.080 |
Why?
|
| International Classification of Diseases | 1 | 2010 | 27 | 0.080 |
Why?
|
| Insurance Claim Review | 1 | 2010 | 37 | 0.080 |
Why?
|
| Dyslipidemias | 1 | 2010 | 48 | 0.080 |
Why?
|
| Women's Health | 1 | 2010 | 160 | 0.070 |
Why?
|
| Curriculum | 1 | 2021 | 318 | 0.070 |
Why?
|
| Cholesterol | 1 | 2010 | 232 | 0.070 |
Why?
|
| Universities | 1 | 2021 | 559 | 0.060 |
Why?
|
| Drug Utilization | 1 | 2006 | 34 | 0.060 |
Why?
|
| Adolescent | 3 | 2024 | 6081 | 0.050 |
Why?
|
| Adult | 5 | 2024 | 13872 | 0.050 |
Why?
|
| Income | 1 | 2024 | 160 | 0.050 |
Why?
|
| Pregnancy | 1 | 2006 | 1772 | 0.040 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2019 | 54 | 0.040 |
Why?
|
| Herpes Zoster | 1 | 2018 | 12 | 0.040 |
Why?
|
| Alleles | 1 | 2019 | 352 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 263 | 0.030 |
Why?
|
| Young Adult | 2 | 2024 | 5080 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2019 | 213 | 0.030 |
Why?
|
| Phenotype | 1 | 2019 | 780 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1124 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 1759 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 452 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2853 | 0.020 |
Why?
|
| Women's Health Services | 1 | 2010 | 12 | 0.020 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2010 | 42 | 0.020 |
Why?
|
| Pediatrics | 1 | 2010 | 70 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 317 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 3994 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2010 | 341 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 611 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2006 | 14 | 0.020 |
Why?
|
| Drug Therapy | 1 | 2006 | 17 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2006 | 29 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 1063 | 0.020 |
Why?
|
| Child | 1 | 2010 | 3443 | 0.010 |
Why?
|